Standard Family Office’s Teradyne TER Stock Holding History

Standard Family Office’s Portfolio TER Stock Details TER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17	Closed	-$1K	–	394
2022 Q3	$1K	Buy	+17	New	+$1.55K	﹤0.01%	472
2021 Q3	–	Sell	-14	Closed	-$2K	–	477
2021 Q2	$2K	Buy	+14	New	+$1.79K	﹤0.01%	431
2021 Q1	–	Sell	-12	Closed	-$1K	–	660
2020 Q4	$1K	Buy	+12	New	+$1.23K	﹤0.01%	556

Other funds holding TER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Standard Family Office's TER Position: Q4 2022 in Review

Standard Family Office sold out of Teradyne (TER) in Q4 2022, closing a stake of 17 shares — an estimated $1K sold.

Standard Family Office first reported a position in TER in Q4 2020 and held it in 3 quarters. The position peaked at $2K in Q2 2021. 642 funds tracked by Wall St. Rank hold TER as of Q4 2022.

Standard Family Office reported no remaining Teradyne position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 17 Teradyne shares in Q4 2022, an estimated $1K.
Standard Family Office first reported a position in Teradyne in Q4 2020 and held it in 3 quarters.
Standard Family Office's Teradyne position peaked at $2K in Q2 2021.
642 funds tracked by Wall St. Rank held Teradyne as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.